Lanreotide Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 60 mg, 90 mg, 120 mg
Reference Brands: omatuline Depot (USA), Somatuline Autogel (USA)
Category: Oncology Cancer Care
Lanreotide is a synthetic octapeptide analogue of somatostatin. It binds to somatostatin receptors (SSTR‑2 and SSTR‑5), inhibiting secretion of growth hormone and other hormones. It is used to treat Acromegaly when surgery/radiotherapy are not suitable and to manage certain neuroendocrine tumours, including gastrointestinal/pancreatic NETs and symptoms of Carcinoid syndrome. Lanreotide is available in Injection and strengths such as 60 mg, 90 mg, 120 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lanreotide is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lanreotide can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lanreotide is used to treat acromegaly, a condition caused by excess growth hormone, and to manage symptoms of certain types of neuroendocrine tumors (NETs), such as carcinoid tumors. It works by mimicking somatostatin, a natural hormone that inhibits the release of growth hormone and other hormones, helping control tumor-related symptoms and hormone levels.
Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It is formulated with excipients that allow slow and sustained release when administered.
The main trade name is Somatuline Depot.
Somatuline Depot is manufactured by Ipsen.
The generic name is lanreotide.
The primary brand name is Somatuline Depot.
Lanreotide is manufactured in GMP-certified facilities by Ipsen and other licensed manufacturers for global distribution.
Related Products
Momelotinib
Strength:
100 mg, 150 mg, 200 mg
Form: Tablets
Reference Brands: Ojjaara (USA)
View Details
Nirogacestat
Strength:
50 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Nintedanib
Strength:
100 mg, 150 mg
Form: Capsules
Reference Brands: Ofev (USA, EU), Vargatef (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
